Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam

Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam

ABSTRACT: Objectives: World Health Organization recommends a 7-drug 9–11-month rifampicin-resistant tuberculosis (RR-TB) short treatment regimen (STR). To reduce the pill burden, we assessed the safety and effectiveness of a 5-drug 9–11-month modified STR (mSTR). Methods: Prospective cohort study o...

Full description

Bibliographic Details
Main Authors:	Thi Mai Phuong Nguyen, Thi Hai Minh Le, Corinne Simone Collette Merle, Debora Pedrazzoli, Nhat Linh Nguyen, Tom Decroo, Binh Hoa Nguyen, Thi Thanh Thuy Hoang, Viet Nhung Nguyen
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	International Journal of Infectious Diseases
Subjects:	Drug-resistant tuberculosis All-oral regimen Shorter regimen Bedaquiline
Online Access:	http://www.sciencedirect.com/science/article/pii/S1201971222005926

Similar Items

Treatment Outcomes of Multidrug-Resistant Tuberculosis Patients in East Java, Indonesia: A Retrospective Cohort Analysis
by: Hardini Tri Indarti, et al.
Published: (2022-01-01)

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
by: Thi Mai Phuong Nguyen, et al.
Published: (2022-10-01)

Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial
by: Nakwon Kwak, et al.
Published: (2022-08-01)

Early efficacy of individual regimens containing bedaquiline in patients with drug resistant tuberculosis
by: Oki Nugraha Putra, et al.
Published: (2023-01-01)

Treatment of Drug-Resistant Tuberculosis: Current Status
by: Rajendra Prasad, et al.
Published: (2021-04-01)

A pragmatic randomized controlled trial to evaluate the efficacy and safety of an oral short-course regimen including bedaquiline for the treatment of patients with multidrug-resistant tuberculosis in China: study protocol for PROSPECT
by: Jingtao Gao, et al.
Published: (2024-04-01)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
by: Tutik Kusmiati, et al.
Published: (2022-08-01)

Extrapulmonary drug-resistant tuberculosis at a drug-resistant tuberculosis center, Mumbai: Our experience – Hope in the midst of despair!
by: Unnati Desai, et al.
Published: (2019-01-01)

New regimens and new medications in the treatment of tuberculosis: keeping step?
by: Ruzanov D.Y., et al.
Published: (2021-04-01)

High Levels of Treatment Success and Zero Relapse in Multidrug-Resistant Tuberculosis Patients Receiving a Levofloxacin-Based Shorter Treatment Regimen in Vietnam
by: Le T. N. Anh, et al.
Published: (2020-03-01)

Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
by: Abdul Wahid, et al.
Published: (2022-09-01)

The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline
by: Muhamad Frendy Setyawan, et al.
Published: (2023-10-01)

Update of drug-resistant tuberculosis treatment guidelines: A turning point
by: Elisa Vanino, et al.
Published: (2023-05-01)

Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
by: Laura Rosu, et al.
Published: (2023-11-01)

Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings
by: Giovanni Sotgiu, et al.
Published: (2017-03-01)

Shorter antibiotic regimens impact the control efforts in high tuberculosis burden regions of Taiwan
by: Yi-Jun Lin, et al.
Published: (2020-08-01)

Factors affecting the treatment outcome of injection based shorter MDR-TB regimen at a referral centre in India
by: Kiran B, et al.
Published: (2022-10-01)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
by: Rajendra Prasad, et al.
Published: (2018-01-01)

Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
by: Malaisamy Muniyandi, et al.
Published: (2022-10-01)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
by: Malaisamy Muniyandi, et al.
Published: (2023-08-01)

The pipeline of new molecules and regimens against drug-resistant tuberculosis
by: Todd A. Black, et al.
Published: (2021-12-01)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
by: Pravin K. Singh, et al.
Published: (2019-09-01)

Effectiveness of the shorter MDR regimen in the management of tuberculosis: Shortfall in the outcome of disease a multidimensional approach and evaluation for a better alternative
by: Prasanta Kumar Das, et al.
Published: (2020-01-01)

Treatment outcomes and adverse drug reactions among patients with drug–resistant tuberculosis receiving all-oral, long–term regimens: First record viewing report from Pakistan
by: Hira Aslam, et al.
Published: (2023-01-01)

Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi
by: François Ciza, et al.
Published: (2020-06-01)

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
by: Yangming Ding, et al.
Published: (2023-10-01)

Colombia: un régimen presidencial bajo la tentación del parlamentarismo
by: Catherine Faivre
Published: (2011-12-01)

Régimen Parlamentario
by: Ráymond Poincare
Published: (1926-09-01)

Bedaquiline in the treatment regimen of multidrugresistant tuberculosis (clinical observation)
by: V. A. Aksenova, et al.
Published: (2020-11-01)

Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish
by: Dupont, Christian, et al.
Published: (2018)

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial
by: Myungsun Lee, et al.
Published: (2019-01-01)

Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study
by: Achalu DL, et al.
Published: (2023-11-01)

Algunas ideas sobre el régimen presidencial
by: Alfonso Cadavid Uribe
Published: (1925-07-01)

Efficacy and safety of regimen containing bedaquiline in children with drug-resistant tuberculosis
by: V. A. Aksenova, et al.
Published: (2021-10-01)

Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant Mycobacterium Tuberculosis Isolates in Zhejiang, China
by: Tong E, et al.
Published: (2023-10-01)

Comparison of bortezomib-cyclophosphamide-dexamethasone <em>versus</em> bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
by: Rafiye Ciftciler, et al.
Published: (2020-05-01)

Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study
by: Christelle Géneviève Jouego, et al.
Published: (2022-11-01)

Debates en torno a la reforma del régimen municipal. Entre la apertura democrática y la restricción. Córdoba, 1923-1925
by: Osella Desirée del Valle
Published: (2020-04-01)

Régimen de incorporación fiscal
by: Emilio Margin Manautou
Published: (2016-12-01)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020
by: Teona Avaliani, et al.
Published: (2021-01-01)